POET's deal with Lumilens is a $500M validation that could move it from lab tech to commercial scale. The supply and joint development agreement starts with a $50M order for optical engines and could scale to $500M over five years, with samples in late 2026 and volume production in 2027. Its optical interposer integrates electronics and photonics in one chip-scale package, beating power-hungry pluggables. 2026 should be the year of validation, 2027 the year of revenue. x.comÂ